Stock Picking: Up to 48.54% in One Month

Stock Picking

This Biotech Stocks forecast is designed for investors and analysts who need predictions of the best performing stocks for the whole Biotechnology Industry (See Industry Package). It includes 20 stocks with bullish and bearish signals and indicates the best biotech stocks to buy:

  • Top 10 biotech stocks for the long position
  • Top 10 biotech stocks for the short position

Package Name: Industry Package – Biotech Stocks
Forecast Length: 1 Month (6/29/15 – 7/29/15)
I Know First Average: 6.34% (Long) and 9.17% (Short)

Stock Picking

In the 1 Month 06/29/2015 forecast that was part of the Biotech package, 11 of the 20 stocks between the long and short positions moved in the direction indicated by the algorithm’s prediction. The top performing stock for the long position was EXEL with a spectacular return of 48.54%, whilst Kite Pharmaceuticals (KITE) also had encouraging returns of 17.63%. The stock that decreased the most in the short position forecast was XOMA with a loss of 78.83%, while MACK also posted significant losses of 19.78% as the algorithm predicted. The average returns for the long and short positions were 6.34% and 9.17% respectively, both of which outperformed the S&P 500 by over 6 percentage points over the same time period.

A company with a mission, Kite Pharmaceuticals pioneers technology to galvanize a cancer patient’s immune system to seek and destroy cancer cells in the body. Engineered autologous cell therapy, or eACT, is the science Kite has developed to genetically enhance T cells to tap and maximize their chimeric antigen receptors. Kite has been making good on its expansion strategy promises and entered into a collaboration agreement with The Leukemia & Lymphoma Society (LLS) for the development of its lead pipeline candidate, KTE-C19, for the treatment of patients with certain types of lymphoma, bumping the stock up in trading month July. Additionally, a steady stream of analysts have been rolling out with bullish calls for Kite, including Maxim, Canaccord Genuity, Mizuho, and Cowen and Company.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First algorithmic traders.

How to interpret this diagram

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.